MedTrace Logo

Baked Milk Oral Immunotherapy for Cow's Milk Allergy

NCT03462030 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2025-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether baked milk oral immunotherapy is safe in the treatment of cow's milk allergy.

Conditions

  • Cow's Milk Allergy

Interventions

DRUG

Baked non-fat cow's milk powder

Oral immunotherapy with increasing quantities of baked milk.

DRUG

Placebo: Tapioca Powder

Placebo control.

Sponsors & Collaborators

  • Myra Reinhardt Foundation

    collaborator OTHER

  • La Jolla Institute for Allergy & Immunology

    collaborator OTHER

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Robert Wood, MD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-15
Primary Completion
2021-01-25
Completion
2024-02-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03462030 on ClinicalTrials.gov